Current Pain and Headache Reports

, Volume 8, Issue 6, pp 468–475

An expansion of Simons’ integrated hypothesis of trigger point formation

  • Robert D. Gerwin
  • Jan Dommerholt
  • Jay P. Shah
Article

Abstract

Simons’ integrated hypothesis proposed a model of trigger point (TrP) activation to explain known TrP phenomena, particularly endplate noise. We propose an expansion of this hypothesis to account for new experimental data and established muscle pathophysiology.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Simons DG, Travell JG, Simons LS: Myofascial Pain and Dysfunction: The Trigger Point Manual, vol 1, edn 2.Baltimore: Williams and Wilkins; 1999. This is the authoritative work in the field. It contains the most comprehensive introduction to myofascial pain and presents the relevant TrP features of each muscle in the upper body.Google Scholar
  2. 2.
    Reinohl J, Hoheisel U, Unger T, Mense S: Adenosine triphosphate as a stimulant for nociceptive and nonnociceptive muscle group IV receptors in the rat. Neurosci Lett 2003, 338:25–28.PubMedCrossRefGoogle Scholar
  3. 3.
    Hubbard DR, Berkoff GM: Myofascial trigger points show spontaneous needle EMG activity. Spine 1993, 18:1803–1807. An article of historic interest. Hubbard and Berkoff first published studies showing the increase in electrical activity at the active TrP site.PubMedCrossRefGoogle Scholar
  4. 4.
    Hong CZ, Yu J: Spontaneous electrical activity of rabbit trigger spot after transection of spinal cord and peripheral nerve. J Musculoskel Pain 1998, 6:45–58.CrossRefGoogle Scholar
  5. 5.
    Simons DG, Hong CZ, Simons L: Prevalence of spontaneous electrical activity at trigger spots and control sites in rabbit muscle. J Musculoskel Pain 1995, 3:35–48.CrossRefGoogle Scholar
  6. 6.
    Simons DG, Hong CZ, Simons L: Endplate potentials are common to midfiber myofascial trigger points. Am J Phys Med Rehabil 2002, 81:212–222. A detailed exploration of the origin and nature of the abnormal electrical activity found in the TrP zone.PubMedCrossRefGoogle Scholar
  7. 7.
    Simons DG, Stololv WC: Microscopic features and transient contraction of palpable bands in canine muscle. Am J Phys Med 1976, 55:65–88.PubMedGoogle Scholar
  8. 8.
    Duxson MJ, Vrbova G: Inhibition of acetylcholinesterase accelerates axon terminal withdrawal at the developing rat neuromuscular junction. J Neurocytol 1985, 14:337–363.PubMedCrossRefGoogle Scholar
  9. 9.
    Hudson CS, Rash JE, Tiedt TN, Albuquerque EX: Neostigmineinduced alterations at the mammalian neuromuscular junction. II: ultrastructure. J Pharmacol Exp Ther 1978, 205:340–356.PubMedGoogle Scholar
  10. 10.
    Blackman JG, Hopkins WG, Milne RJ, Peterson DW: Supercontracture at endplates of mammalian muscle fibers caused by decamethonium and related agonists. Proc Univ Otago Med Sch 1978, 56:71–72.Google Scholar
  11. 11.
    Reitinger A, Radner H, Tilscher H, et al.: Morphologische untersuchung an triggerpunkten. Manuelle Medizin 1996, 34:256–262.Google Scholar
  12. 12.
    Windisch A, Reitinger A, Traxler H, et al.: Morphology and histochemistry of myelogelosis. Clin Anat 1999, 12:266–271.PubMedCrossRefGoogle Scholar
  13. 13.
    Shah J, Phillips T, Danoff JV, Gerber L: A novel microanalytical technique for assaying soft tissue demonstrates significant quantitative biochemical differences in 3 clinically distinct groups: normal, latent, and active. Arch Phys Med Rehabil 2003, 84:A4. This is an exciting preliminary report describing the biochemical changes in the active TrP milieu. It is the first study to report such changes.CrossRefGoogle Scholar
  14. 14.
    Graven-Nielsen T, Jansson Y, Segerdahl M, et al.: Experimental pain by ischaemic contractions compared with pain by intramuscular infusions of adenosine and hypertonic saline. Eur J Pain 2003, 7:93–102.PubMedCrossRefGoogle Scholar
  15. 15.
    Barlas P, Walsh DM, Baxter GD, Allen JM: Delayed onset muscle soreness: effect of an ischemic block upon mechanical allodynia in humans. Pain 2000, 87:221–225.PubMedCrossRefGoogle Scholar
  16. 16.
    Crenshaw AG, Thornell LE, Friden J: Intramuscular pressure, torque, and swelling for the exercise-induced sore vastus lateralis muscle. Acta Physiol Scand 1994, 152:265–277.PubMedGoogle Scholar
  17. 17.
    Stauber WT, Clarkson PM, Fritz VK, Evans WJ: Extracellular matrix disruption and pain after eccentric muscle action. J Appl Physiol 1990, 69:868–874. A well-done study showing the effect of eccentric contraction on muscle integrity and describing the cellular disruption that occurs with eccentric contraction.PubMedGoogle Scholar
  18. 18.
    Trappe TA, Carrithers JA, White F, et al.: Titin and nebulin content in human skeletal muscle following eccentric resistance exercise. Muscle Nerve 2002, 25:289–292.PubMedCrossRefGoogle Scholar
  19. 19.
    Proske U, Morgan DL: Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation, and clinical applications. J Physiol 2001, 537:333–345.PubMedCrossRefGoogle Scholar
  20. 20.
    Mense S: The pathogenesis of muscle pain. Curr Pain Headache Rep 2003, 7:419–425. Mense presents the most thorough discussion of the pathophysiology of muscle pain and relates it to myofascial pain.PubMedCrossRefGoogle Scholar
  21. 21.
    Gregory JE, Morgan DL, Proske U: Tendon organs as monitors of muscle damage from eccentric contractions. Exp Brain Res 2003, 151:346–355.PubMedCrossRefGoogle Scholar
  22. 22.
    Larsson R, Oberg A, Larsson SE: Changes of trapezius muscle blood flow and electromyography in chronic neck pain due to trapezius myalgia. Pain 1999, 79:45–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Delchano RE, Kim YJ, Clark GT: Hemodynamics changes induced by submaximal isometric contraction in painful and non-painful human masseter using near infrared spectroscopy. Arch Oral Biol 1996, 41:585–596.CrossRefGoogle Scholar
  24. 24.
    Maekawa K, Clark GT, Kuboki T: Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 2002, 3:251–260. This is a critical review of the role of hypoperfusion in muscle symptomatolgy.PubMedCrossRefGoogle Scholar
  25. 25.
    Brückle W, Sückfull M, Fleckenstein W, et al.: Gewebe-pO2-Messung in der verspannten Rückenmuskulatur (m. erector spinae). Z Rheumatol 1990, 49:208–216.PubMedGoogle Scholar
  26. 26.
    Kadi F, Waling K, Ahlgren C, et al.: Pathological mechanisms implicated in localized female trapezius myalgia. Pain 1998, 78:191–196.PubMedCrossRefGoogle Scholar
  27. 27.
    Kadi F, Hagg G, Hakansson R, et al.: Structural changes in male trapezius muscle with work-related myalgia. Acta Neuropathol 1998, 95:352–360.PubMedCrossRefGoogle Scholar
  28. 28.
    Chen JT, Chen SM, Kuan TS, et al.: Phentolamine effect on the spontaneous electrical activity of active loci in a myofascial trigger spot of rabbit skeletal muscle. Arch Phys Med Rehabil 1998, 79:790–794. A well-done study quantifying the diminution of abnormal spontaneous electrical activity at the TrP after the administration of the adrenergic antagonist phentolamine.PubMedCrossRefGoogle Scholar
  29. 29.
    Graven-Nielsen T, Arendt-Nielsen L: Is there a relation between intramuscular hypoperfusion and chronic muscle pain? J Pain 2002, 3:261–263.PubMedCrossRefGoogle Scholar
  30. 30.
    Mense S: Do we know enough to put forward a unifying hypothesis? J Pain 2002, 3:264–266.PubMedCrossRefGoogle Scholar
  31. 31.
    Byrne C, Twist C, Eston R: Neuromuscular function after exercise-induced muscle damage: theoretical and applied implications. Sports Med 2004, 34:46–46.CrossRefGoogle Scholar
  32. 32.
    Brockett C, Warren N, Gregory JE, et al.: A comparison of the effects of concentric versus eccentric exercise on force and position sense at the human elbow joint. Brain Res 1997, 771:251–258.PubMedCrossRefGoogle Scholar
  33. 33.
    Lieber RL, Shah S, Friden J: Cytoskeletal disruption after eccentric contraction-induced muscle injury. Clin Orthop 2002, 403(suppl):S90-S99.PubMedCrossRefGoogle Scholar
  34. 34.
    Lieber RL, Thornell LE, Friden J: Muscle cytoskeletal disruption occurs within the first 15 min of cyclic eccentric contraction. J Appl Physiol 1996, 80:278–284.PubMedCrossRefGoogle Scholar
  35. 35.
    Peters D, Barash IA, Burdi M, et al.: Asynchronous functional, cellular, and transcriptional changes after a bout of eccentric in the rat. J Physiol 2003, 553:947–957.PubMedCrossRefGoogle Scholar
  36. 36.
    Friden J, Lieber RL: Segmental muscle fiber lesions after repetitive eccentric contractions. Cell Tissue Res 1998, 293:165–171.PubMedCrossRefGoogle Scholar
  37. 37.
    Yu JG, Malm C, Thornell LE: Eccentric contractions leading to DOMS do not cause loss of desmin nor fiber necrosis in human muscle. Histochem Cell Biol 2002, 118:29–34.PubMedGoogle Scholar
  38. 38.
    Yu JG, Furst DO, Thornell LE: The mode of myofibril remodeling in human skeletal muscle affected by DOMS induced by eccentric contractions. Histochem Cell Biol 2003, 119:383–393.PubMedGoogle Scholar
  39. 39.
    Yu JG, Thornell LE: Desmin and actin alterations in human muscles affected by delayed onset soreness: a high resolution immunocytochemical study. Histochem Cell Biol 2002, 118:171–179.PubMedGoogle Scholar
  40. 40.
    Itoh K, Okada K, Kawakita K: A proposed experimental model of myofascial trigger points in humans after slow eccentric exercise. Acupunct Med 2004, 22:2–13.PubMedCrossRefGoogle Scholar
  41. 41.
    Stauber WT, Fritz VK, Vogelbach DW, Dahlmann B: Characterization of muscles injured by forced lengthening. I: cellular infiltrates. Med Sci Sports Exerc 1988, 20:345–353.PubMedCrossRefGoogle Scholar
  42. 42.
    Perez AC, Cabral de Oliveira AC, Esteves E, et al.: Mitochondrial, sarcoplasmic membrane integrity, and protein degradation in heart and skeletal muscle in exercised rats. Comp Biochem Physiol C 2003, 134:199–206.CrossRefGoogle Scholar
  43. 43.
    Sacheck JM, Milbury PE, Cannon JG, et al.: Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men. Free Radic Biol Med 2003, 34:1575–1588.PubMedCrossRefGoogle Scholar
  44. 44.
    Davies K, Quintanilha A, Brooks A, Packer I: Free radical tissue damage produced by exercise. Biochem Res Commun 1982, 107:1178–1205.Google Scholar
  45. 45.
    McBride J, Kraemer W, Triplett-McBride T, Sebastianelli W: Effect of resistance exercise on free radical production. Med Sci Sports Exerc 1998, 30:67–72.PubMedGoogle Scholar
  46. 46.
    Fernandez HL, Chen M, Nadelhaft I, Durr JA: Calcitonin gene-related peptides: their binding sites and receptor accessory proteins in adult mammalian skeletal muscles. Neuroscience 2003, 119:335–345. This is the most complete and up-to-date discussion of the role of CGRP in modulation of myo-neuro-junction function.PubMedCrossRefGoogle Scholar
  47. 47.
    Fernandez HL, Ross GS, Nadelhaft I: Neurogenic calcitonin gene-related peptide: a neurotrophic factor in the maintenance of acetylcholinesterase molecular forms in adult skeletal muscles. Brain Res 1999, 844:83–97.PubMedCrossRefGoogle Scholar
  48. 48.
    Hodges-Savola C, Fernandez HL: A role for calcitonin gene-related peptide in the regulation of rat skeletal muscle G4 acetylcholinesterase. Neurosci Lett 1995, 190:117–120.PubMedCrossRefGoogle Scholar
  49. 49.
    Salim SY, Dezaki K, Tsuneki H, et al.: Calcitonin gene-related peptide potentiates nicotinic acetylcholine receptor-operated slow Ca2+ mobilization at mouse muscle endplates. Br J Pharmacol 1998, 125:277–282.PubMedCrossRefGoogle Scholar
  50. 50.
    Rossi SG, Dickerson IM, Rotundo RL: Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and it role in regulating acetylcholinesterase expression. J Biol Chem 2003, 278:24994–24500.PubMedCrossRefGoogle Scholar
  51. 51.
    Jinnai K, Chihara K, Kanda F, et al.: Calcitonin gene-related peptide enhances spontaneous acetylcholine release from the rat motor nerve terminal. Neurosci Lett 1989, 103:64–68.PubMedCrossRefGoogle Scholar
  52. 52.
    Kimura I, Okazaki M, Nojima H: Mutual dependence of calcitonin-gene related peptide and acetylcholine release in neuromuscular preparations. Eur J Pharmacol 1997, 330:123–128.PubMedCrossRefGoogle Scholar
  53. 53.
    Kovyazina IV, Nikolsky EE, Giniatullin RA, et al.: Dependence of miniature endplate current on kinetic parameters of acetylcholine receptors activation: a model study. Neurochem Res 2003, 28:443–448.PubMedCrossRefGoogle Scholar
  54. 54.
    Dolezal V, Tucek S: Effects of tetrodotoxin, Ca2+ absence, d-tubocararine and vesamicol on spontaneous acetylcholine release from rat muscle. J Physiol 1992, 458:1–9.PubMedGoogle Scholar
  55. 55.
    Wessler I: Acetylcholine release at motor endplates and autonomic neuroeffector junctions: a comparison. Pharmacol Res 1996, 33:81–94.PubMedCrossRefGoogle Scholar
  56. 56.
    Bowman WC, Marshall IG, Gibb AJ, Harbone AJ: Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci 1988, 9:16–20.PubMedCrossRefGoogle Scholar
  57. 57.
    Sluka KA, Kalra A, Moore SA: Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001, 24:37–46. The authors discuss the important effect of an acidic milieu on acetylcholinesterase and on the function of the myoneurojunction.PubMedCrossRefGoogle Scholar
  58. 58.
    Sluka KA, Price MP, Breese NM, et al.: Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 2003, 106:229–239.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Robert D. Gerwin
    • 1
  • Jan Dommerholt
  • Jay P. Shah
  1. 1.Johns Hopkins University, Pain and Rehabilitation MedicineBethesdaUSA

Personalised recommendations